LillyDirect is Eli Lilly's own direct-to-patient channel, letting people fill FDA-approved Zepbound and Mounjaro through a self-pay pharmacy rather than a telehealth middleman or a compounding pharmacy.
Overview
Most GLP-1 telehealth companies sit between you and a pharmacy. LillyDirect removes one layer: the medication comes from the company that actually manufactures it, dispensed through the LillyDirect Self Pay Pharmacy and shipped to your home.
That structure answers the single biggest question hanging over the compounded GLP-1 market, which is what exactly is in the vial. With LillyDirect you are receiving the same FDA-approved product a retail pharmacy would dispense, with the manufacturer's own labelling and quality controls.
What LillyDirect does not do is act as a full weight-management program. It is a pharmacy channel. Prescribing happens through your own clinician or through independent telehealth platforms Lilly links to, and there is no coaching, nutrition support, or dedicated care team included in the price.
LillyDirect at a Glance
| Detail | What LillyDirect Publishes |
|---|---|
| Type of company | Pharmaceutical manufacturer's direct-to-patient pharmacy channel |
| Medications | Zepbound (tirzepatide) and Mounjaro (tirzepatide) |
| Formulation | FDA-approved brand-name only; no compounded products |
| Semaglutide offered | No, Lilly does not manufacture semaglutide |
| Prescriber | Your own clinician, or an independent telehealth platform Lilly links to |
| States served | United States; residency required |
| Insurance billing | Self-pay pharmacy channel; savings card available separately for commercial insurance |
Medications Offered
- Zepbound (tirzepatide) single-patient-use KwikPen
- Zepbound (tirzepatide) single-dose vials
- Mounjaro (tirzepatide) for type 2 diabetes
- No semaglutide products, since these are Novo Nordisk medications
- No compounded formulations of any kind
Brand-Name or Compounded?
Entirely brand-name. Everything dispensed is the FDA-approved product manufactured by Eli Lilly, which is the central reason to use this channel rather than a compounded telehealth program. If you want compounded semaglutide or compounded tirzepatide at a lower price point, LillyDirect is not the right door.
Consultation Process
Get a prescription
You need a valid Zepbound or Mounjaro prescription first, either from your own clinician or through an independent telehealth platform.
Enrol in the pharmacy
Set up an account with the LillyDirect Self Pay Pharmacy and choose between self-pay pricing or the commercial savings card route.
Prescription is routed
Your prescriber sends the prescription to LillyDirect rather than a retail pharmacy.
Home delivery
The medication ships to your home from the LillyDirect pharmacy.
Eligibility
- You must have a valid prescription for Zepbound or Mounjaro
- Clinical eligibility is decided by your prescriber, not by Lilly
- Zepbound is FDA-approved for chronic weight management and for obstructive sleep apnea in adults with obesity
- Mounjaro is FDA-approved for type 2 diabetes
- Self-pay pricing requires paying outside of insurance benefits
Provider Involvement and Lab Requirements
Provider Involvement
LillyDirect is a pharmacy channel, not a medical practice. Prescribing is done by your own clinician or by independent telehealth providers Lilly links to from its site. Ongoing clinical follow-up is whatever your prescriber offers.
Lab Requirements
LillyDirect does not publish a lab requirement of its own. Any lab work is at the discretion of the clinician writing your prescription.
Pharmacy Fulfillment and Shipping
Pharmacy Fulfillment
Dispensed through the LillyDirect Self Pay Pharmacy. Because Lilly manufactures the medication, there is no third-party compounding pharmacy in the chain and no 503A or 503B sourcing question to investigate.
Shipping Frequency
Shipped to your home from the LillyDirect pharmacy on the fill schedule your prescription specifies, typically monthly. Tirzepatide requires refrigeration, so shipments arrive in temperature-controlled packaging.
Support Services
- Pharmacy support for order and fill questions
- Savings card enrolment help for commercially insured patients
- No coaching, dietitian, or behavioural program included
- Clinical questions go back to your prescriber, not to Lilly
Pricing
Lilly publishes self-pay pricing directly, which is unusual in this market and makes comparison straightforward. Pricing below is what Lilly published at the time of review for the single-patient-use KwikPen.
| Plan or Medication | Published Price | What It Covers |
|---|---|---|
| Zepbound 2.5 mg | $299 per month | One month of the single-patient-use KwikPen, or four vials |
| Zepbound 5 mg | $399 per month | One month of the single-patient-use KwikPen |
| Zepbound 7.5 mg to 15 mg | $699 per month | One month of the single-patient-use KwikPen at higher strengths |
| Commercial savings card | As little as $25 | For eligible commercially insured patients, with monthly and annual savings caps |
Pricing reflects what LillyDirect published at the time of review and can change without notice. Confirm current pricing directly with the provider before enrolling.
Membership Fees
None. LillyDirect is a pharmacy channel rather than a subscription program, so there is no membership or platform fee. You pay for medication only.
Medication Fees
Medication is the entire cost. Self-pay pricing published by Lilly ranges from $299 per month at the 2.5 mg starting strength up to $699 per month for the 7.5 mg through 15 mg KwikPen strengths.
Cancellation and Refund Policy
Cancellation
There is no subscription to cancel. You simply stop filling the prescription. Any ongoing telehealth relationship you used to obtain the prescription is cancelled separately with that provider.
Refunds
Refund terms are set by pharmacy policy. As with any dispensed prescription medication, filled prescriptions generally cannot be returned. Confirm current terms with LillyDirect before ordering.
Insurance, HSA and FSA
Insurance
The self-pay pharmacy channel is designed to be used outside insurance. Separately, Lilly offers a savings card for eligible commercially insured patients that can bring a fill down to as little as $25, subject to published monthly and annual maximums. Patients with government insurance are generally not eligible for the savings card and must self-pay outside their benefit.
HSA / FSA
Prescription medication is normally an eligible HSA and FSA expense in the United States. Confirm with your plan administrator, and keep your pharmacy receipt for substantiation.
For a fuller explanation of how these accounts work with GLP-1 care, see our GLP-1 insurance, HSA and FSA guide.
Who LillyDirect May Be Best For
- You specifically want FDA-approved Zepbound rather than a compounded copy
- You are starting at 2.5 mg or 5 mg, where self-pay pricing is most competitive
- You already have a prescriber and do not need a program wrapped around the medication
- You want no ambiguity about pharmacy sourcing or potency
- You have commercial insurance and can use the savings card
- Higher strengths jump to $699 per month, well above compounded pricing
- No semaglutide option, so Wegovy or Ozempic seekers must look elsewhere
- No coaching, dietitian, or behavioural support bundled in
- You still need to source a prescriber separately
- Government-insured patients typically cannot use the savings card
Alternatives to Consider
NovoCare Pharmacy
The equivalent manufacturer-direct channel from Novo Nordisk, for Wegovy rather than Zepbound.
CoreAge Rx
Our top-rated telehealth option, with lower compounded pricing and a care team included.
Klinic
Brand-name-only telehealth that will bill insurance, if you would rather not self-pay.
Precision Telemed
Flat-rate compounded tirzepatide that does not rise as you titrate upward.
You can also compare the whole field in our GLP-1 provider comparison and best online GLP-1 providers roundups.
Frequently Asked Questions
Is LillyDirect cheaper than a compounded tirzepatide program?
At the 2.5 mg starting strength, LillyDirect's published $299 per month is broadly comparable to mid-priced compounded programs. At 7.5 mg and above, the published $699 per month is considerably more than most compounded providers charge. The trade-off you are buying is an FDA-approved product.
Does LillyDirect provide the telehealth visit?
No. LillyDirect is a pharmacy channel. You need a prescription from your own clinician or from an independent telehealth platform. Lilly links to third-party telehealth options but does not employ the prescribers.
Can I get semaglutide through LillyDirect?
No. Semaglutide, the active ingredient in Ozempic and Wegovy, is made by Novo Nordisk. LillyDirect only dispenses Eli Lilly's own products, which for weight management means tirzepatide.
Is the medication the same as what a retail pharmacy dispenses?
Yes. LillyDirect dispenses the same FDA-approved Zepbound and Mounjaro that any pharmacy would, manufactured by Eli Lilly.
Can I use insurance with LillyDirect self-pay pricing?
The self-pay channel is designed to be used outside insurance. Commercially insured patients may instead use Lilly's savings card, which is a separate program with its own eligibility rules and savings caps.
What is the difference between the vial and the KwikPen?
Both deliver tirzepatide. The single-dose vial requires drawing the dose with a syringe, while the KwikPen is a pre-filled injector. Lilly's published $299 entry price covers either the KwikPen for single-patient use or four vials.
Medical Disclaimer
This review is for general information only and is not medical advice, a diagnosis, or a treatment recommendation. GLP-1 medications are prescription drugs with real risks and contraindications. Only a licensed clinician who knows your history can decide whether any medication is appropriate for you. Never start, stop, or change a prescription based on this page. If you have a medical emergency, call 911.
Details on this page describe what LillyDirect published at the time of review. Programs, pricing, pharmacy partners, and policies change; verify everything directly with the provider before enrolling. See our full medical disclaimer.
Date reviewed: August 24, 2026